Brooks Automation and Cleveland Clinic have opened a 22,000-square-foot biospecimen sample management and repository facility on Cleveland Clinic’s main campus.
The biorepository is managed by Azenta Life Sciences, Brooks’ recently re-branded life sciences division, and includes ultra-cold and cryogenic storage for researchers at Cleveland Clinic and other institutions. The new facility increases biobanking capacity at Cleveland Clinic and will help accelerate translational research.
“Biobanking is essential for the evolution of personalised medicine for conditions, such as heart disease, cancer and epilepsy,” said Serpil Erzurum, Cleveland Clinic’s Chief Research and Academic Officer. “This technologically advanced biorepository will enable research that allows us the knowledge to provide the best care for all people as part of Cleveland Clinic’s mission: caring for life, researching for health, educating those who serve.”
“The storage of biological samples safely and efficiently is an integral part of the research process allowing researchers to focus on breakthroughs in areas, such as personalised medicine and therapeutic development,” added Sarah Eckenrode, Vice President, Sample & Repository Solutions, Azenta Life Sciences. “The onsite sample biorepository standardises sample collection, processing and storage protocols to increase scalability and efficiencies for Cleveland Clinic’s high-value collections of biological material.”
In addition to the biorepository, the building will also serve as a community resource to improve awareness of ongoing research and career opportunities in the medical and scientific field. This includes a community room – a research access centre – where members of the local community can learn more about medical research.
Image credit: Cleveland Clinic BioRepository
